Cayman
Showing 22351–22500 of 45550 results
-
Leucine-rich repeat kinase 2 (LRRK2) is an enzyme that interacts with parkin, a ligase that is part of the ubiquitin-proteasome system that mediates the targeting of proteins for degradation. Loss of function of the parkin protein leads to dopaminergic cell death. The development of Parkinson’s disease has been strongly associated with mutations in the LRRK2 gene that lead to increased kinase activity. GNE-7915 is a selective, brain-penetrable LRRK2 inhibitor (Kis = 2 and 18.7 nM in biochemical and cell-based assays, respectively).{27842} It inhibits LRRK2 Ser1292 autophosphorylation in BAC transgenic mice expressing human LRRK2 protein with the G2019S Parkinson’s disease mutation with an IC50 value of 20 nM in vivo.{27842}
Brand:CaymanSKU:-
GNE-9065 is an orally bioavailable and potent inhibitor of leucine-rich repeat kinase 2 (LRRK2; IC50 = 18.7 nM).{27842} It is selective for LRRK2 over 178 kinases, inhibiting only TAK1-TAB1 >50% at a concentration of 0.1 μM. GNE-9065 (10 and 50 mg/kg) inhibits LRRK2 Ser1292 autophosphorylation in BAC transgenic mice expressing human LRRK2 protein with the G2019S mutation found in families with autosomal Parkinson’s disease.
Brand:CaymanSKU:23446 - 1 mgAvailable on backorder
GNE-9065 is an orally bioavailable and potent inhibitor of leucine-rich repeat kinase 2 (LRRK2; IC50 = 18.7 nM).{27842} It is selective for LRRK2 over 178 kinases, inhibiting only TAK1-TAB1 >50% at a concentration of 0.1 μM. GNE-9065 (10 and 50 mg/kg) inhibits LRRK2 Ser1292 autophosphorylation in BAC transgenic mice expressing human LRRK2 protein with the G2019S mutation found in families with autosomal Parkinson’s disease.
Brand:CaymanSKU:23446 - 10 mgAvailable on backorder
GNE-9065 is an orally bioavailable and potent inhibitor of leucine-rich repeat kinase 2 (LRRK2; IC50 = 18.7 nM).{27842} It is selective for LRRK2 over 178 kinases, inhibiting only TAK1-TAB1 >50% at a concentration of 0.1 μM. GNE-9065 (10 and 50 mg/kg) inhibits LRRK2 Ser1292 autophosphorylation in BAC transgenic mice expressing human LRRK2 protein with the G2019S mutation found in families with autosomal Parkinson’s disease.
Brand:CaymanSKU:23446 - 25 mgAvailable on backorder
GNE-9065 is an orally bioavailable and potent inhibitor of leucine-rich repeat kinase 2 (LRRK2; IC50 = 18.7 nM).{27842} It is selective for LRRK2 over 178 kinases, inhibiting only TAK1-TAB1 >50% at a concentration of 0.1 μM. GNE-9065 (10 and 50 mg/kg) inhibits LRRK2 Ser1292 autophosphorylation in BAC transgenic mice expressing human LRRK2 protein with the G2019S mutation found in families with autosomal Parkinson’s disease.
Brand:CaymanSKU:23446 - 5 mgAvailable on backorder
GNF-2 is an allosteric inhibitor of Bcr-Abl (IC50 = 267 nM).{28970} It is selective for Bcr-Abl over c-Abl and a panel of 63 additional kinases at 10 µM. It inhibits proliferation of Ba/F3 cells (IC50 = 138 nM). GNF-2 (10 µM) reduces viral titers in Vero cells infected with infectious bronchitis virus (IBV), a coronavirus, via inhibition of IBV surface glycoprotein-induced syncytia formation and virus-cell fusion.{45828} It inhibits LPS-induced production of nitric oxide (NO) and TNF-α in BV-2 microglia when used at concentrations of 10 and 20 µM.{59702} GNF-2 (1 and 10 mg/kg) reduces paw edema and increases the latency to paw withdrawal in a mouse model of inflammatory pain induced by complete Freund’s adjuvant (CFA). It also decreases mechanical and thermal hyperalgesia in a mouse model of diabetic neuropathy induced by streptozotocin (STZ; Item No. 13104).
Brand:CaymanSKU:- GNF-2 is an allosteric inhibitor of Bcr-Abl (IC50 = 267 nM).{28970} It is selective for Bcr-Abl over c-Abl and a panel of 63 additional kinases at 10 µM. It inhibits proliferation of Ba/F3 cells (IC50 = 138 nM). GNF-2 (10 µM) reduces viral titers in Vero cells infected with infectious bronchitis virus (IBV), a coronavirus, via inhibition of IBV surface glycoprotein-induced syncytia formation and virus-cell fusion.{45828} It inhibits LPS-induced production of nitric oxide (NO) and TNF-α in BV-2 microglia when used at concentrations of 10 and 20 µM.{59702} GNF-2 (1 and 10 mg/kg) reduces paw edema and increases the latency to paw withdrawal in a mouse model of inflammatory pain induced by complete Freund’s adjuvant (CFA). It also decreases mechanical and thermal hyperalgesia in a mouse model of diabetic neuropathy induced by streptozotocin (STZ; Item No. 13104).
Brand:CaymanSKU:- GNF-2 is an allosteric inhibitor of Bcr-Abl (IC50 = 267 nM).{28970} It is selective for Bcr-Abl over c-Abl and a panel of 63 additional kinases at 10 µM. It inhibits proliferation of Ba/F3 cells (IC50 = 138 nM). GNF-2 (10 µM) reduces viral titers in Vero cells infected with infectious bronchitis virus (IBV), a coronavirus, via inhibition of IBV surface glycoprotein-induced syncytia formation and virus-cell fusion.{45828} It inhibits LPS-induced production of nitric oxide (NO) and TNF-α in BV-2 microglia when used at concentrations of 10 and 20 µM.{59702} GNF-2 (1 and 10 mg/kg) reduces paw edema and increases the latency to paw withdrawal in a mouse model of inflammatory pain induced by complete Freund’s adjuvant (CFA). It also decreases mechanical and thermal hyperalgesia in a mouse model of diabetic neuropathy induced by streptozotocin (STZ; Item No. 13104).
Brand:CaymanSKU:- GNF-2 is an allosteric inhibitor of Bcr-Abl (IC50 = 267 nM).{28970} It is selective for Bcr-Abl over c-Abl and a panel of 63 additional kinases at 10 µM. It inhibits proliferation of Ba/F3 cells (IC50 = 138 nM). GNF-2 (10 µM) reduces viral titers in Vero cells infected with infectious bronchitis virus (IBV), a coronavirus, via inhibition of IBV surface glycoprotein-induced syncytia formation and virus-cell fusion.{45828} It inhibits LPS-induced production of nitric oxide (NO) and TNF-α in BV-2 microglia when used at concentrations of 10 and 20 µM.{59702} GNF-2 (1 and 10 mg/kg) reduces paw edema and increases the latency to paw withdrawal in a mouse model of inflammatory pain induced by complete Freund’s adjuvant (CFA). It also decreases mechanical and thermal hyperalgesia in a mouse model of diabetic neuropathy induced by streptozotocin (STZ; Item No. 13104).
Brand:CaymanSKU:-
GNF-5 is an allosteric inhibitor of Bcr-Abl (IC50 = 0.121 µM) and a derivative of GNF-2 (Item No. 16253).{61146} It also inhibits the Bcr-Abl mutants Bcr-AblG250E, Bcr-AblE255V, and Bcr-AblM351T (IC50s = 4.52, 0.38, and 0.93 µM, respectively).{30754} GNF-5 inhibits the growth of Ba/F3 cells (IC50 = 0.145 µM).{61146} It reduces viral titers in Vero cells infected with infectious bronchitis virus (IBV), a coronavirus, when used at a concentration of 10 µM via inhibition of IBV surface glycoprotein-induced syncytia formation and virus-cell fusion.{45828} GNF-5 (75 mg/kg) increases survival in a recalcitrant mutant Bcr-AblT315I mouse bone marrow transplantation model when administered alone or in combination with nilotinib.{30754}
Brand:CaymanSKU:- GNF-5 is an allosteric inhibitor of Bcr-Abl (IC50 = 0.121 µM) and a derivative of GNF-2 (Item No. 16253).{61146} It also inhibits the Bcr-Abl mutants Bcr-AblG250E, Bcr-AblE255V, and Bcr-AblM351T (IC50s = 4.52, 0.38, and 0.93 µM, respectively).{30754} GNF-5 inhibits the growth of Ba/F3 cells (IC50 = 0.145 µM).{61146} It reduces viral titers in Vero cells infected with infectious bronchitis virus (IBV), a coronavirus, when used at a concentration of 10 µM via inhibition of IBV surface glycoprotein-induced syncytia formation and virus-cell fusion.{45828} GNF-5 (75 mg/kg) increases survival in a recalcitrant mutant Bcr-AblT315I mouse bone marrow transplantation model when administered alone or in combination with nilotinib.{30754}
Brand:CaymanSKU:- GNF-5 is an allosteric inhibitor of Bcr-Abl (IC50 = 0.121 µM) and a derivative of GNF-2 (Item No. 16253).{61146} It also inhibits the Bcr-Abl mutants Bcr-AblG250E, Bcr-AblE255V, and Bcr-AblM351T (IC50s = 4.52, 0.38, and 0.93 µM, respectively).{30754} GNF-5 inhibits the growth of Ba/F3 cells (IC50 = 0.145 µM).{61146} It reduces viral titers in Vero cells infected with infectious bronchitis virus (IBV), a coronavirus, when used at a concentration of 10 µM via inhibition of IBV surface glycoprotein-induced syncytia formation and virus-cell fusion.{45828} GNF-5 (75 mg/kg) increases survival in a recalcitrant mutant Bcr-AblT315I mouse bone marrow transplantation model when administered alone or in combination with nilotinib.{30754}
Brand:CaymanSKU:- GNF-5 is an allosteric inhibitor of Bcr-Abl (IC50 = 0.121 µM) and a derivative of GNF-2 (Item No. 16253).{61146} It also inhibits the Bcr-Abl mutants Bcr-AblG250E, Bcr-AblE255V, and Bcr-AblM351T (IC50s = 4.52, 0.38, and 0.93 µM, respectively).{30754} GNF-5 inhibits the growth of Ba/F3 cells (IC50 = 0.145 µM).{61146} It reduces viral titers in Vero cells infected with infectious bronchitis virus (IBV), a coronavirus, when used at a concentration of 10 µM via inhibition of IBV surface glycoprotein-induced syncytia formation and virus-cell fusion.{45828} GNF-5 (75 mg/kg) increases survival in a recalcitrant mutant Bcr-AblT315I mouse bone marrow transplantation model when administered alone or in combination with nilotinib.{30754}
Brand:CaymanSKU:-
Tropomyosin-related kinases (Trks) are receptor tyrosine kinases activated by peptides, including neurotrophins. They have prominent roles in the development of central and peripheral nervous systems, vascular cell survival, and cancer.{30894} Rearrangement of genes for Trks with the transcription factor Tel, producing Tel-Trk fusion proteins, are associated with various types of cancer.{30895,30893} GNF-5837 is a potent, bioavailable pan-Trk inhibitor that blocks the proliferation of cells expressing Tel-TrkA, Tel-TrkB, and Tel-TrkC (IC50s = 7, 9, and 11 nM, respectively).{30893} It less effectively inhibits c-Kit and PDGFRβ (IC50s = 0.91 and 0.87 µM, respectively), while requiring micromolar concentrations to inhibit an array of other receptor and non-receptor tyrosine kinases. GNF-5837 inhibits the growth of Ba/F3 and rat intestinal epithelial (RIE) cells expressing both TrkA and nerve growth factor (NGF) with IC50 values of 42 and 17 nM, respectively, but does not have anti-proliferative activity of parental cells at concentrations up to 10 µM.{30893} GNF-5837 displays good bioavailability in mice and rats when given intravenously but not orally.{30893} It induces regression of tumor xenografts derived from RIE cells expressing both TrkA and NGF.{30893}
Brand:CaymanSKU:- Tropomyosin-related kinases (Trks) are receptor tyrosine kinases activated by peptides, including neurotrophins. They have prominent roles in the development of central and peripheral nervous systems, vascular cell survival, and cancer.{30894} Rearrangement of genes for Trks with the transcription factor Tel, producing Tel-Trk fusion proteins, are associated with various types of cancer.{30895,30893} GNF-5837 is a potent, bioavailable pan-Trk inhibitor that blocks the proliferation of cells expressing Tel-TrkA, Tel-TrkB, and Tel-TrkC (IC50s = 7, 9, and 11 nM, respectively).{30893} It less effectively inhibits c-Kit and PDGFRβ (IC50s = 0.91 and 0.87 µM, respectively), while requiring micromolar concentrations to inhibit an array of other receptor and non-receptor tyrosine kinases. GNF-5837 inhibits the growth of Ba/F3 and rat intestinal epithelial (RIE) cells expressing both TrkA and nerve growth factor (NGF) with IC50 values of 42 and 17 nM, respectively, but does not have anti-proliferative activity of parental cells at concentrations up to 10 µM.{30893} GNF-5837 displays good bioavailability in mice and rats when given intravenously but not orally.{30893} It induces regression of tumor xenografts derived from RIE cells expressing both TrkA and NGF.{30893}
Brand:CaymanSKU:- Tropomyosin-related kinases (Trks) are receptor tyrosine kinases activated by peptides, including neurotrophins. They have prominent roles in the development of central and peripheral nervous systems, vascular cell survival, and cancer.{30894} Rearrangement of genes for Trks with the transcription factor Tel, producing Tel-Trk fusion proteins, are associated with various types of cancer.{30895,30893} GNF-5837 is a potent, bioavailable pan-Trk inhibitor that blocks the proliferation of cells expressing Tel-TrkA, Tel-TrkB, and Tel-TrkC (IC50s = 7, 9, and 11 nM, respectively).{30893} It less effectively inhibits c-Kit and PDGFRβ (IC50s = 0.91 and 0.87 µM, respectively), while requiring micromolar concentrations to inhibit an array of other receptor and non-receptor tyrosine kinases. GNF-5837 inhibits the growth of Ba/F3 and rat intestinal epithelial (RIE) cells expressing both TrkA and nerve growth factor (NGF) with IC50 values of 42 and 17 nM, respectively, but does not have anti-proliferative activity of parental cells at concentrations up to 10 µM.{30893} GNF-5837 displays good bioavailability in mice and rats when given intravenously but not orally.{30893} It induces regression of tumor xenografts derived from RIE cells expressing both TrkA and NGF.{30893}
Brand:CaymanSKU:-
GNF-7 is a multi-kinase inhibitor (IC50s = 25, 8, 61, 122, 136, and 133 nM for ACK1, GCK, Bcr-AblT315I, Bcr-AblE255V, Bcr-AblG250E, and c-Abl, respectively).{45192,45193} It also inhibits several additional kinases in a panel by greater than 50% when used at a concentration of 10 μM.{45193} GNF-7 inhibits the growth of Ba/F3 cells transformed with wild-type Bcr-Abl, Bcr-AblT315I, Bcr-AblE255V, and Bcr-AblG250E (IC50s = 50s = 1 and 5 nM, respectively) in vitro. In vivo, GNF-7 (10 and 20 mg/kg) reduces tumor growth in a Bcr-AblT315I Ba/F3 mouse xenograft model. It also reduces tumor volume in an OCI-AML3 mouse xenograft model when administered at a dose of 8 mg/kg.{45192}
Brand:CaymanSKU:19918 -Available on backorder
GNF-7 is a multi-kinase inhibitor (IC50s = 25, 8, 61, 122, 136, and 133 nM for ACK1, GCK, Bcr-AblT315I, Bcr-AblE255V, Bcr-AblG250E, and c-Abl, respectively).{45192,45193} It also inhibits several additional kinases in a panel by greater than 50% when used at a concentration of 10 μM.{45193} GNF-7 inhibits the growth of Ba/F3 cells transformed with wild-type Bcr-Abl, Bcr-AblT315I, Bcr-AblE255V, and Bcr-AblG250E (IC50s = 50s = 1 and 5 nM, respectively) in vitro. In vivo, GNF-7 (10 and 20 mg/kg) reduces tumor growth in a Bcr-AblT315I Ba/F3 mouse xenograft model. It also reduces tumor volume in an OCI-AML3 mouse xenograft model when administered at a dose of 8 mg/kg.{45192}
Brand:CaymanSKU:19918 -Available on backorder
GNF-7 is a multi-kinase inhibitor (IC50s = 25, 8, 61, 122, 136, and 133 nM for ACK1, GCK, Bcr-AblT315I, Bcr-AblE255V, Bcr-AblG250E, and c-Abl, respectively).{45192,45193} It also inhibits several additional kinases in a panel by greater than 50% when used at a concentration of 10 μM.{45193} GNF-7 inhibits the growth of Ba/F3 cells transformed with wild-type Bcr-Abl, Bcr-AblT315I, Bcr-AblE255V, and Bcr-AblG250E (IC50s = 50s = 1 and 5 nM, respectively) in vitro. In vivo, GNF-7 (10 and 20 mg/kg) reduces tumor growth in a Bcr-AblT315I Ba/F3 mouse xenograft model. It also reduces tumor volume in an OCI-AML3 mouse xenograft model when administered at a dose of 8 mg/kg.{45192}
Brand:CaymanSKU:19918 -Available on backorder
GNF-7 is a multi-kinase inhibitor (IC50s = 25, 8, 61, 122, 136, and 133 nM for ACK1, GCK, Bcr-AblT315I, Bcr-AblE255V, Bcr-AblG250E, and c-Abl, respectively).{45192,45193} It also inhibits several additional kinases in a panel by greater than 50% when used at a concentration of 10 μM.{45193} GNF-7 inhibits the growth of Ba/F3 cells transformed with wild-type Bcr-Abl, Bcr-AblT315I, Bcr-AblE255V, and Bcr-AblG250E (IC50s = 50s = 1 and 5 nM, respectively) in vitro. In vivo, GNF-7 (10 and 20 mg/kg) reduces tumor growth in a Bcr-AblT315I Ba/F3 mouse xenograft model. It also reduces tumor volume in an OCI-AML3 mouse xenograft model when administered at a dose of 8 mg/kg.{45192}
Brand:CaymanSKU:19918 -Available on backorder
Brand:CaymanSKU:10008856 - 200 µlAvailable on backorder
Brand:CaymanSKU:10008856- 200 µlAvailable on backorder
Brand:CaymanSKU:10008856- 200 µl
Gö 6976 is a nonglycosidic indolocarbazole that inhibits protein kinase C (PKC) with IC50 values of 2.3 and 6.2 nM for PKCα and PKCβ1, respectively.{9057} It does not inhibit the activity of PKCδ, PKCε, or PKCζ (IC50s > 3 μM), indicating a preference for the Ca2+-dependent subtypes, PKCα and PKCβ1.{9057} Gö 6976 also inhibits the checkpoint kinases Chk1/2.{30717} It was shown to abrogate DNA damage-induced S- and G2-phase cell cycle arrest, leading to cytotoxicity in p53 mutant tumor cells.{30717,24026}
Brand:CaymanSKU:- Gö 6976 is a nonglycosidic indolocarbazole that inhibits protein kinase C (PKC) with IC50 values of 2.3 and 6.2 nM for PKCα and PKCβ1, respectively.{9057} It does not inhibit the activity of PKCδ, PKCε, or PKCζ (IC50s > 3 μM), indicating a preference for the Ca2+-dependent subtypes, PKCα and PKCβ1.{9057} Gö 6976 also inhibits the checkpoint kinases Chk1/2.{30717} It was shown to abrogate DNA damage-induced S- and G2-phase cell cycle arrest, leading to cytotoxicity in p53 mutant tumor cells.{30717,24026}
Brand:CaymanSKU:- Gö 6976 is a nonglycosidic indolocarbazole that inhibits protein kinase C (PKC) with IC50 values of 2.3 and 6.2 nM for PKCα and PKCβ1, respectively.{9057} It does not inhibit the activity of PKCδ, PKCε, or PKCζ (IC50s > 3 μM), indicating a preference for the Ca2+-dependent subtypes, PKCα and PKCβ1.{9057} Gö 6976 also inhibits the checkpoint kinases Chk1/2.{30717} It was shown to abrogate DNA damage-induced S- and G2-phase cell cycle arrest, leading to cytotoxicity in p53 mutant tumor cells.{30717,24026}
Brand:CaymanSKU:-
Gö 6983 inhibits several isoforms of protein kinase C (PKC; IC50 = 7, 7, 6, 10, 60, and 20,000 nM for PKCα, PKCβ, PKCγ, PKCδ, PKCζ, and PKCμ, respectively).{9055} It provides cardioprotective effects in myocardial ischemia/reperfusion by attenuating contractile dysfunction.{17421,17420}
Brand:CaymanSKU:- Gö 6983 inhibits several isoforms of protein kinase C (PKC; IC50 = 7, 7, 6, 10, 60, and 20,000 nM for PKCα, PKCβ, PKCγ, PKCδ, PKCζ, and PKCμ, respectively).{9055} It provides cardioprotective effects in myocardial ischemia/reperfusion by attenuating contractile dysfunction.{17421,17420}
Brand:CaymanSKU:- Gö 6983 inhibits several isoforms of protein kinase C (PKC; IC50 = 7, 7, 6, 10, 60, and 20,000 nM for PKCα, PKCβ, PKCγ, PKCδ, PKCζ, and PKCμ, respectively).{9055} It provides cardioprotective effects in myocardial ischemia/reperfusion by attenuating contractile dysfunction.{17421,17420}
Brand:CaymanSKU:- Brand:CaymanSKU:13391- 100 μg Goat anti-Chicken IgY conjugated to SureLight® APC Antibody: Goat polyclonal anti-chicken IgY Dye: SureLight® Allophycocyanin (APC) Excitation max. λ: 650 nm Emission max. λ: 660 nm Uses: Flow cytometry and cell-based assays
Brand:CaymanSKU:13391 - 100 μgAvailable on backorder
Brand:CaymanSKU:13391- 100 μgAvailable on backorder
Brand:CaymanSKU:13413- 1 ea Goat anti-Chicken IgY conjugated to SureLight® R-PE Antibody: Goat polyclonal anti-chicken IgY Dye: SureLight® R-phycoerythrin Excitation max. λ: 565>498 nm Emission max. λ: 578 nm Uses: Flow cytometry, cell-based assays, microarrays, and microplate applications
Brand:CaymanSKU:13413 - 1 eaAvailable on backorder
Brand:CaymanSKU:13413- 1 eaAvailable on backorder
Immunogen: Synthetic peptide from the C-terminal region of human COX-2 • Host: Goat • Cross Reactivity: (−) COX-1 from all species • Species Reactivity: (+) Human, mouse, ovine, and rat COX-2 • Application(s): IF, IHC, and WB • Expression of COX-2, the inducible form of COX, is regulated by growth factor tumors, tumor promoters, bacterial endotoxin, and cytokines
Brand:CaymanSKU:100034- 1 eaAvailable on backorder
Immunogen: Synthetic peptide from the C-terminal region of human COX-2 • Host: Goat • Cross Reactivity: (−) COX-1 from all species • Species Reactivity: (+) Human, mouse, ovine, and rat COX-2 • Application(s): IF, IHC, and WB • Expression of COX-2, the inducible form of COX, is regulated by growth factor tumors, tumor promoters, bacterial endotoxin, and cytokines
Brand:CaymanSKU:100034- 1 ea Cyclooxygenase (COX) catalyzes the first step in the biosynthesis of prostaglandins (PGs), thromboxanes, and prostacyclins: the conversion of arachidonic acid to PGH2. Discoveries of the induction of COX by a variety of stimuli such as phorbol esters, lipopolysaccharides, and cytokines led to the hypothesis that the inducible form of COX, COX-2, is responsible for the biosynthesis of PGs under acute inflammatory conditions.{4,3463} COX-2 is a 72 kDa protein which has been cloned from a variety of species including human, mouse, rat, and ovine.{2,7,2884,4051}
Brand:CaymanSKU:100034 - 1 eaAvailable on backorder
Brand:CaymanSKU:13461- 100 μg Goat anti-GST (Glutathione-S-Transferase) IgG conjugated to Alkaline Phosphatase Antibody: Goat polyclonal anti-Glutathione-S-Transferase Enzyme: Alkaline Phosphatase Uses: Western blot detection. Recommended dilution of 1:500-1:10,000. Starting dilution: 1:2,000.
Brand:CaymanSKU:13461 - 100 μgAvailable on backorder
Brand:CaymanSKU:13461- 100 μgAvailable on backorder
Brand:CaymanSKU:11245- 100 μg Goat anti-GST (Glutathione-S-Transferase) IgG conjugated to DyLight® 488 Antibody: Goat polyclonal anti-GST (Glutathione-S-Transferase) IgG Dye: DyLight® 488 Excitation max. λ: 493 nm Emission max. λ: 518 nm Uses: Flow cytometry, cell-based assays, microarrays, and microplate applications
Brand:CaymanSKU:11245 - 100 μgAvailable on backorder
Brand:CaymanSKU:11245- 100 μgAvailable on backorder
Brand:CaymanSKU:11254- 100 μg Goat anti-GST (Glutathione-S-Transferase) IgG conjugated to DyLight® 550 Antibody: Goat polyclonal anti-GST (Glutathione-S-Transferase) IgG Dye: DyLight® 550 Excitation max. λ: 562 nm Emission max. λ: 576 nm Uses: Flow cytometry, cell-based assays, microarrays, and microplate applications
Brand:CaymanSKU:11254 - 100 μgAvailable on backorder
Brand:CaymanSKU:11254- 100 μgAvailable on backorder
Brand:CaymanSKU:11263- 100 μg Goat anti-GST (Glutathione-S-Transferase) IgG conjugated to DyLight® 650 Antibody: Goat polyclonal anti-GST (Glutathione-S-Transferase) IgG Dye: DyLight® 650 Excitation max. λ: 652 nm Emission max. λ: 672 nm Uses: Flow cytometry, cell-based assays, microarrays, and microplate applications
Brand:CaymanSKU:11263 - 100 μgAvailable on backorder
Brand:CaymanSKU:11263- 100 μgAvailable on backorder
Brand:CaymanSKU:16575- 1 mgAvailable on backorder
Brand:CaymanSKU:16575- 1 mg Antibody: Goat polyclonal anti-GST (Glutathione-S-Transferase) IgG Dye: Europium Chelate W-1024 Excitation max. λ: 340 nm Emission max. λ: 615 nm Uses: TR-FRET high throughput screening (HTS) applications (LANCE®, HTRF®)
Brand:CaymanSKU:16575 - 1 mgAvailable on backorder
Brand:CaymanSKU:16575- 20 µgAvailable on backorder
Brand:CaymanSKU:16575- 20 µg Antibody: Goat polyclonal anti-GST (Glutathione-S-Transferase) IgG Dye: Europium Chelate W-1024 Excitation max. λ: 340 nm Emission max. λ: 615 nm Uses: TR-FRET high throughput screening (HTS) applications (LANCE®, HTRF®)
Brand:CaymanSKU:16575 - 20 µgAvailable on backorder
Brand:CaymanSKU:16575- 50 µgAvailable on backorder
Brand:CaymanSKU:16575- 50 µg Antibody: Goat polyclonal anti-GST (Glutathione-S-Transferase) IgG Dye: Europium Chelate W-1024 Excitation max. λ: 340 nm Emission max. λ: 615 nm Uses: TR-FRET high throughput screening (HTS) applications (LANCE®, HTRF®)
Brand:CaymanSKU:16575 - 50 µgAvailable on backorder
Brand:CaymanSKU:16598- 1 mgAvailable on backorder
Brand:CaymanSKU:16598- 1 mg Goat anti-GST (Glutathione-S-Transferase) IgG conjugated to SureLight® APC Antibody: Goat polyclonal anti-GST (Glutathione-S-Transferase) IgG Dye: SureLight® Allophycocyanin (APC) Excitation max. λ: 652 nm Emission max. λ: 657.5 nm Uses: Optimized for High throughput screening (HTS) and fluorescence resonance energy transfer (FRET) assays, flow cytometry, and microscopy
Brand:CaymanSKU:16598 - 1 mgAvailable on backorder
Brand:CaymanSKU:16598- 100 µgAvailable on backorder
Brand:CaymanSKU:16598- 100 µg Goat anti-GST (Glutathione-S-Transferase) IgG conjugated to SureLight® APC Antibody: Goat polyclonal anti-GST (Glutathione-S-Transferase) IgG Dye: SureLight® Allophycocyanin (APC) Excitation max. λ: 652 nm Emission max. λ: 657.5 nm Uses: Optimized for High throughput screening (HTS) and fluorescence resonance energy transfer (FRET) assays, flow cytometry, and microscopy
Brand:CaymanSKU:16598 - 100 µgAvailable on backorder
Brand:CaymanSKU:13448- 100 μg Goat anti-GST (Glutathione-S-Transferase) IgG conjugated to SureLight® P3 Antibody: Goat polyclonal anti-Glutathione-S-Transferase (GST) Dye: SureLight® P3 Excitation max. λ: 614 nm Emission max. λ: 662 nm Uses: Flow cytometry, cell-based assays, microarrays, and microplate applications
Brand:CaymanSKU:13448 - 100 μgAvailable on backorder
Brand:CaymanSKU:13448- 100 μgAvailable on backorder
Brand:CaymanSKU:11272- 100 μg Goat anti-GST (Glutathione-S-Transferase) IgG conjugated to SureLight® PerCP Antibody: Goat polyclonal anti-GST (Glutathione-S-Transferase) IgG Dye: SureLight® Peridinin-Chlorophyll (PerCP) Excitation max. λ: 483 nm Emission max. λ: 673 nm Uses: Flow cytometry, cell-based assays, microarrays, and microplate applications
Brand:CaymanSKU:11272 - 100 μgAvailable on backorder
Brand:CaymanSKU:11272- 100 μgAvailable on backorder
Brand:CaymanSKU:13422- 1 ea Goat anti-GST (Glutathione-S-Transferase) IgG conjugated to SureLight® R-PE Antibody: Goat polyclonal anti-GST (Glutathione-S-Transferase) IgG Dye: SureLight® R-phycoerythrin Excitation max. λ: 565>498 nm Emission max. λ: 578 nm Uses: Flow cytometry, cell-based assays, microarrays, and microplate applications
Brand:CaymanSKU:13422 - 1 eaAvailable on backorder
Brand:CaymanSKU:13422- 1 eaAvailable on backorder
Goat anti-Human IgG, H+L conjugated to HRP Antibody: Goat polyclonal anti-Human IgG Enzyme: Horseradish Peroxidase Uses: Western blot detection. Recommended dilution of 1:500-1:10,000. Starting dilution: 1:2,000.
Brand:CaymanSKU:16703 - 1 mgAvailable on backorder
Brand:CaymanSKU:16703- 1 mgAvailable on backorder
Brand:CaymanSKU:16703- 1 mg Brand:CaymanSKU:16584- 100 µgAvailable on backorder
Brand:CaymanSKU:16584- 100 µg Spectral Characteristics: Visible absorption maximum = 652 nm, Emission maximum = 657 nm; This polyclonal antibody detects human IgA, tagged with SureLight® APC.
Brand:CaymanSKU:16584 - 100 µgAvailable on backorder
Goat anti-Human IgA conjugated to SureLight® R-PE Antibody: Goat polyclonal anti-Human IgA Dye: SureLight® R-phycoerythrin Excitation max. λ: 565>498 nm Emission max. λ: 578 nm Uses: Flow cytometry, cell-based assays, microarrays, and microplate applications
Brand:CaymanSKU:16639 - 100 µgAvailable on backorder